TLR7 and COVID-19: Ex vivo stimulation of pDCs, DCs, and monocyte–macrophages isolated from the peripheral blood of COVID-19 patients with the TLR7 loss-of-function variant resulted in reduced IFN/ISG levels compared to the cells from control COVID-19 patients (53, –, 55, 80, 81).